Download the Whitepaper
Setting A New-Standard for Migraine Research
Migraine is classified as a highly prevalent neurological disease, affecting over 1.1 billion people worldwide and ranking as the second leading cause of disability. Migraines are not merely just a pain syndrome, but a complex neurological disorder involving altered neurophysiological states and progressive changes in brain networks.
As migraine research continues to evolve, so do the challenges of conducting trials, with ambitious endpoints and complex designs. In this new whitepaper, Medpace experts discuss everything you need to know to prepare for migraine clinical research .
Migraine is classified as a highly prevalent neurological disease, affecting over 1.1 billion people worldwide and ranking as the second leading cause of disability. Migraines are not merely just a pain syndrome, but a complex neurological disorder involving altered neurophysiological states and progressive changes in brain networks.
As migraine research continues to evolve, so do the challenges of conducting trials, with ambitious endpoints and complex designs. In this new whitepaper, Medpace experts discuss everything you need to know to prepare for migraine clinical research .
Making the Complex Seamless® in Migraine Pain Clinical Research
Gain a competitive advantage for your program by partnering with a global clinical research organization (CRO) that understands the challenges of drug and device development in pain and has the necessary expertise and experience to help you overcome them.
The Medpace neuroscience team has conducted studies focused on neuroscience, specifically pain and pain-related indications, in collaboration with reputable pain specialists around the world. Our expert knowledge of complex study designs based on therapeutic depth, patient recruitment, project management, regulatory issues, as well as noteworthy relationships with key investigative sites, helps to ensure that projects are completed on time and on budget.
